Table 6.

Derived indices of the 9-week captopril-treated diabetic group

Parameter	Value	P
Left ventricular output (LVOP) (l min−1)	0.067 ± 0.005*†	<0.001
LVOP/body weight (l min−1 kg−1)	0.270 ± 0.013†	<0.001
LVOP/heart weight (l min−1 g−1)	0.11 ± 0.006†	<0.001
Maximum left ventricular power (MLVP) (W)	0.02 ± 0.003*†	<0.001
MLVP/body weight (mW g−1)	0.083 ± 0.008†	<0.001
MLVP/heart weight (W g−1)	0.034 ± 0.003†	<0.001
Maximum left ventricular stroke work (MLVSW) (J)	0.004 ± 0.0004*†	<0.001
MLVSW/body weight (mJ g−1)	0.016 ± 0.001†	<0.001
MLVSW/heart weight (J g−1)	0.006 ± 0.0005†	<0.001
Left ventricular systolic elastance (mmHg μl−1)	1.04 ± 0.04†	0.001
LVMV (μl)/LVEDV (μl)	1.3 ± 0.04†	<0.001
RVMV (μl)/RVEDV (μl)	0.45 ± 0.015†	<0.001

All values expressed as mean ± s.e.m.; n = 4. One-way ANOVA was used in comparison of the control and the two groups diabetic from age 7 weeks followed (the group spared captopril treatment and the group treated with captopril) by Tukey's Honestly Significant Difference test for pair-wise multiple comparisons. A value of P <0.05 was considered statistically significant.

^*Significantly different from the control group.

^†Significantly different from the similarly diabetic group spared captopril treatment.